Pharmacogenomics in Drug Discovery and Development

Pharmacogenomics in Drug Discovery and Development

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Yan, Qing. (Editor)
Format: eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2008.
Edition:1st ed. 2008.
Series:Methods in Molecular Biology, 448
Subjects:
Medicinal chemistry.
Pharmacology.
Human genetics.
Cell biology.
Bioinformatics.
Medicinal Chemistry.
Pharmacology/Toxicology.
Human Genetics.
Cell Biology.
Online Access:https://doi.org/10.1007/978-1-59745-205-2
LEADER 02241nam a22003855i 4500
001 978-1-59745-205-2
005 20191027002601.0
007 cr nn 008mamaa
008 100301s2008 xxu| s |||| 0|eng d
020 |a 9781597452052 
024 7 |a 10.1007/978-1-59745-205-2  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Pharmacogenomics in Drug Discovery and Development  |c edited by Qing Yan. 
250 |a 1st ed. 2008. 
260 # # |a Totowa, NJ :  |b Humana Press :  |b Imprint: Humana,  |c 2008. 
300 |a XIII, 487 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods in Molecular Biology,  |v 448 
505 0 |a The Integration of Personalized and Systems Medicine -- Applications of Microarrays and Biochips in Pharmacogenomics -- Confounding in Genetic Association Studies and Its Solutions -- Pharmacogenetics of Membrane Transporters -- Pharmacogenomics of Drug-Metabolizing Enzymes and Drug Transporters in Chemotherapy -- Pharmacogenomics of G Protein-Coupled Receptor -- G Protein-Coupled Receptors Disrupted in Human Genetic Disease -- G Protein-Coupled Receptor Pharmacogenetics -- Epigenetic Alterations of the Dopaminergic System in Major Psychiatric Disorders -- Pharmacogenomics in Alzheimer's Disease -- Pharmacogenetics of Asthma -- From SNPs to Functional Studies in Cardiovascular Pharmacogenomics -- Pharmacogenomics in Gastrointestinal Disorders -- Pharmacogenomics in Rheumatoid Arthritis -- Cancer Pharmacogenetics -- Pharmacogenomics in the Preclinical Development of Vaccines -- Pharmacogenomics in the Evaluation of Efficacy and Adverse Events During Clinical Development of Vaccines. 
650 0 |a Medicinal chemistry. 
650 0 |a Pharmacology. 
650 0 |a Human genetics. 
650 0 |a Cell biology. 
650 0 |a Bioinformatics. 
650 1 4 |a Medicinal Chemistry. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Human Genetics. 
650 2 4 |a Cell Biology. 
650 2 4 |a Bioinformatics. 
700 1 |a Yan, Qing.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-1-59745-205-2 

Similar Items